Read More 1 minute read News Product News ReSync Bio Launches with Funding to Accelerate Drug Discovery Key Highlights ReSync Bio launches with backing from Caffeinated Capital, Atria Ventures, and angel investors. Platform bridges digital and… byChris-Anne RoqueSeptember 30, 2024